DISCO Pharmaceuticals
PrivateLast Round
Seed
Dec 11, 2025
Total Funding Raised
$63.8M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
DISCO Pharmaceuticals is a biotechnology company that operates a surfaceome mapping platform designed to identify novel cancer-selective targets for the development of antibody-based therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
DISCO Pharmaceuticals Comparables
Compare DISCO Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cartography Biosciences | 86% | |
| Protai | 84% | |
| ProFound Therapeutics | 82% |
DISCO Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Dec 11, 2025 | ||||
| Seed | Jan 16, 2024 |
Key People
Founding team and executive leadership
DISCO Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ackermans & van Haaren | Seed |
| M Ventures | Seed |
| AbbVie Ventures | Seed |
| Panakès Partners | Seed |
| NRW.Bank | Seed |
| Sofinnova Partners | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 75% MoM.
- Mar 2, 2026
Monthly visitors grew 102% MoM, reaching 3.6K.
DISCO Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about DISCO Pharmaceuticals's valuation, stock price, and market status.
Is DISCO Pharmaceuticals a public or private company?
DISCO Pharmaceuticals is a private company.
What is the current stock price of DISCO Pharmaceuticals?
DISCO Pharmaceuticals is a private company with no public stock price. No recent secondary market data is available.
How much is DISCO Pharmaceuticals worth (valuation)?
Valuation information for DISCO Pharmaceuticals is not publicly available.
Can I buy DISCO Pharmaceuticals stock?
DISCO Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was DISCO Pharmaceuticals's last funding round?
DISCO Pharmaceuticals's most recent funding round was Seed on January 16, 2024.
Who are the main investors in DISCO Pharmaceuticals?
Key investors in DISCO Pharmaceuticals include Sofinnova Partners.
Will DISCO Pharmaceuticals IPO soon?
No public IPO plans have been announced for DISCO Pharmaceuticals.
How can I track DISCO Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor DISCO Pharmaceuticals's secondary market activity and sign up for updates.